Actively hiring
Neurology & CNS Therapeutics
Biotechnology
Health Care
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Team
51-200
employees, estimated range
Backers
1
Kurma Partners
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
2019
Founded
Registers and programsofficial lists and records that name the company
| Legal entity | Vico Therapeutics B.V. | its site |
Backed byfrom the funds' portfolios and accelerator catalogs
Similar startupsby what they do, their industry and backers

Brenig Therapeutics develops innovative small-molecule therapies for neurodegenerative diseases, including LRRK2 inhibitors targeting…

A biotech company dedicated to developing transformative medicines for people with neurodegenerative diseases using cutting-edge science…

Verge Labs has spent a decade building one of the most comprehensive proprietary human tissue datasets in neurological disease.

Lario Therapeutics are developing first-in-class disease modifying treatments for severe neurological disorders. Precision Neuroscience…

Developing transformative medicines for neurological and mental health disorders.

Augustine Therapeutics is developing selective, safe and efficacious HDAC6 inhibitors designed for treatment of neuromuscular…
Overview
Pioneering RNA-based science to target the root cause of rare genetic neurological diseases VO659: The first clinical candidate directly targeting the CAG repea.

Kurma Partners